ImmuGuard Yellow Fever Vaccine - Strong Defense Against Yellow Fever
ProcurenetShort description
Yellow Fever Vaccine – Your Armor Against Yellow Fever
A live, attenuated virus vaccine prequalified by the WHO, uniquely formulated from the 17D strain for active immunization against yellow fever, for those over 6 months of age. Key features:
- Vaccine Design: Live, 17D strain attenuated virus vaccine.
- Quality: World Health Organization (WHO) certified.
- Intended Users: Suitable for adults and children over 6 months for active immunization.
- Dosage Guidelines: A 0.5ml dose, either intramuscularly or deep subcutaneously in the upper arm.
- Storage Requirements: Store at 2u00b0C to 8u00b0C.
- Protection: Single dose offers at least 30 years of immunity.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
ImmuGuard Yellow Fever Vaccine - Secure Shield Against Yellow Fever
Detailed Overview:
The ImmuGuard Yellow Fever Vaccine is a powerful and effective immunizing agent crafted to offer staunch protection against the threat of Yellow Fever. A potent viral disease, Yellow Fever is primarily transmitted through mosquito bites and can potentially be fatal. Our vaccine is based on the 17D strain, containing a live but attenuated virus developed meticulously in eggs. It fosters a formidable defense against the disease, ensuring health and safety.
Prime Features:
- An effective live attenuated virus vaccine aimed to combat Yellow Fever.
- Derived from the rigorously grown 17D strain virus in eggs using freeze-drying techniques.
- Safe to be administered to both adults and infants over 6 months of age.
- Designed for intramuscular or subcutaneous injection, preferably in the upper arm, for ease of administration.
- Each application requires a volume of 0.5ml per injection.
- Mandatory utilization of a sterile needle and syringe for each injection to maintain safety and hygiene.
- Needs to be shielded from direct exposure to sunlight.
- The reconstituted vaccine must be consumed within the day of preparation and requires storage in the temperature range of 2°C to 8°C.
Administration Advisory:
The administration of the ImmuGuard Yellow Fever Vaccine is recommended soon after a child completes 6 months of age or when there is a high risk of contracting the virus. In numerous nations, this timeline is integrated with that of the routine measles vaccination, usually at 9 months. The vaccine can be safely given in conjunction with other vaccines, enabling smooth and efficient immunization programs.
Ace protection can persist between thirty years to an entire lifetime for a majority of the recipients. As per the International Certificate of Vaccination, a dose is marked valid for a decade, commencing ten days after inoculation.
Transportation & Conservation:
- Always maintain the carrying and storage temperature between 2°C and 8°C.
- The vaccine vials and the diluters should always be stored and transported together for safety.
